ACTRN12622000243718尚未招募未知
Comparative assessment of anti-diabetic efficacy of metformin plus dapagliflozin with metformin plus insulin- sensitizer or secretagogues in patients with diabetes mellitus type-2 in Pakistan: A randomized trial.
Dr. Malik Hassan Mehmood0 个研究点目标入组 84 人开始时间: 2022年2月10日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 84
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 30 Years 至 80 Years（—）
- 性别
- All
入选标准
- •1) Subject having Type-2 diabetes mellitus
- •2) Both Male & Female
- •3)Patients having glycated hemoglobin ranging between 6.5 to 12.5%
- •4)Age from 30 to 80 year
- •5)BMI greater than 23 kg/m^2
- •6)Patients who can understand and give consent for study
排除标准
- •1)Patients not using any oral anti diabetic combination from previous 4 weeks.
- •2)Subject having type 1 diabetes mellitus.
- •3)Person with history of blood pressure greater than 180 mm of Hg
- •4)Pregnancy
- •5)Patients with renal insufficiency
- •6) Lactating females
- •7) Dementia
研究者
相似试验
已完成
不适用
The Clinical Comparison of Antidiabetic Agents Treating Postprandial Hyperglycemia, between Repaglinide alone and Mitiglide/Voglibose Fixed-dose Combination using Continuous Glucose Monitoring on Postprandial Profiles.JPRN-UMIN000025235Dokkyo Medical University30
招募中
不适用
Kaphaja Pramehahara Yoga, an Ayurveda formulation in Pre-Diabetes.CTRI/2022/07/044484Ministry of AYUSH Govt of India
已完成
不适用
A Pilot study of anti-diabetic effects of rich Oligosaccharides fraction which is taken from Rosa arvensis in patients with type 2 diabetesIRCT2013120214333N13Barekat Pharmaceutical Company40
招募中
3 期
Anti-diabetic Herbal DrugDiabetes type2.oral antidiabetic drugsZ79.84IRCT20170809035599N2Ahvaz University of Medical Sciences140
尚未招募
不适用
Comparative efficacy and safety of antidiabetic drugs in treating diabetes mellitusType 2 DiabetesJPRN-UMIN000032496The University of Tokyo10,000